Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 2884
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
This article has been cited by
1Free fatty acid-induced histone acetyltransferase activity accelerates lipid accumulation in HepG2 cells
Sangwon Chung,Jin-Taek Hwang,Jae Ho Park,Hyo-Kyoung Choi
Nutrition Research and Practice.2019;13(3)196
[DOI]
2To Protect Fatty Livers from Ischemia Reperfusion Injury: Role of Ischemic Postconditioning
Julia Schewe,Marie-Christine Makeschin,Andrej Khandoga,Jiang Zhang,Doris Mayr,Simon Rothenfußer,Max Schnurr,Alexander L. Gerbes,Christian J. Steib
Digestive Diseases and Sciences.2021;66(4)1349
[DOI]
3Histopathological and biochemical changes in the development of nonalcoholic fatty liver disease induced by high-sucrose diet at different times
Selene de Jesús Acosta-Cota,Elsa Maribel Aguilar-Medina,Rosalio Ramos-Payán,Ana Karen Ruiz-Quiñónez,José Geovanni Romero-Quintana,Julio Montes-Avila,José Guadalupe Rendón-Maldonado,Araceli Sánchez-López,David Centurión,Ulises Osuna-Martínez
Canadian Journal of Physiology and Pharmacology.2019;97(1)23
[DOI]
4Hígado graso no alcohólico. Papel de los médicos de atención primaria
Juan Caballeria,Llorenç Caballeria
Medicina Clínica.2015;145(3)112
[DOI]
5Esteatosis hepática: diagnóstico y seguimiento
Llorenç Caballería Rovira,Irfan Majeed,Alba Martínez Escudé,Ingrid Arteaga Pillasagua,Pere Torán Monserrat
FMC - Formación Médica Continuada en Atención Primaria.2017;24(7)378
[DOI]
6Therapeutic effect of treatment with metformin and/or 4-hydroxychalcone in male Wistar rats with nonalcoholic fatty liver disease
Selene de Jesús Acosta-Cota,Elsa Maribel Aguilar-Medina,Rosalío Ramos-Payán,José Guadalupe Rendón Maldonado,José Geovanni Romero-Quintana,Julio Montes-Avila,Juan I. Sarmiento-Sánchez,Carolina Gabriela Plazas-Guerrero,Marcela J. Vergara-Jiménez,Araceli Sánchez-López,David Centurión,Ulises Osuna-Martínez
European Journal of Pharmacology.2019;863(7)172699
[DOI]
7Nuciferine downregulates Per-Arnt-Sim kinase expression during its alleviation of lipogenesis and inflammation on oleic acid-induced hepatic steatosis in HepG2 cells
Dan-Dan Zhang,Ji-Gang Zhang,Xin Wu,Ying Liu,Sheng-Ying Gu,Guan-Hua Zhu,Yu-Zhu Wang,Gao-Lin Liu,Xiao-Yu Li
Frontiers in Pharmacology.2015;6(7)172699
[DOI]
8Effect of Helicobacter pylori on insulin resistance in nonobese, nondiabetic, and normolipidemic Egyptian patients
Ahmed S. Allam,Somia Bawady,Ahmed S. Abdel-Moaty,Sarah El-Nakeep
Egyptian Liver Journal.2018;8(1)23
[DOI]
9Environmental Risk Factors for Liver Cancer and Nonalcoholic Fatty Liver Disease
Trang VoPham
Current Epidemiology Reports.2019;6(1)50
[DOI]
10Chronic systemic exposure to IL6 leads to deregulation of glycolysis and fat accumulation in the zebrafish liver
Manoj K. Singh,Rijith Jayarajan,Swati Varshney,Sindhuri Upadrasta,Archana Singh,Rajni Yadav,Vinod Scaria,Shantanu Sengupta,Dhanasekaran Shanmugam,Dhanasekaran Shalimar,Sridhar Sivasubbu,Sheetal Gandotra,Chetana Sachidanandan
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.2021;1866(5)158905
[DOI]
11Haplotype analysis of the HFE gene among populations of Northern Eurasia, in patients with metabolic disorders or stomach cancer, and in long-lived people
S. V. Mikhailova,V. N. Babenko,D. E. Ivanoshchuk,M. A. Gubina,V. N. Maksimov,I. G. Solovjova,M. I. Voevoda
BMC Genetics.2016;17(1)158905
[DOI]
12Preclinical models of non-alcoholic fatty liver disease
Prasanna K. Santhekadur,Divya P. Kumar,Arun J. Sanyal
Journal of Hepatology.2018;68(2)230
[DOI]
13Non-alcoholic fatty liver disease (NAFLD): survey of awareness and understanding among professionals in secondary care
Bronwen Williams,Nurun Tania,Lynsey Corless
Gastrointestinal Nursing.2019;17(Sup6)S22
[DOI]
14Fatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition
Takanori Ohata,Hideki Yokoo,Toshiya Kamiyama,Moto Fukai,Takeshi Aiyama,Yutaka Hatanaka,Kanako Hatanaka,Kenji Wakayama,Tatsuya Orimo,Tatsuhiko Kakisaka,Nozomi Kobayashi,Yoshihiro Matsuno,Akinobu Taketomi
Cancer Medicine.2017;6(5)1049
[DOI]
15The association of the steatosis severity, NAFLD fibrosis score and FIB-4 index with atherogenic dyslipidaemia in adult patients with NAFLD: A cross-sectional study
Helda Tutunchi,Fatemeh Naeini,Mehrangiz Ebrahimi-mameghani,Majid Mobasseri,Sina Naghshi,Alireza Ostadrahimi
International Journal of Clinical Practice.2021;6(5)1049
[DOI]
16DNA methylation alters transcriptional rates of differentially expressed genes and contributes to pathophysiology in mice fed a high fat diet
Pili Zhang,Tianjiao Chu,N. Dedousis,Benjamin S. Mantell,Ian Sipula,Lucy Li,Kimberly D. Bunce,Patricia A. Shaw,Liora S. Katz,Jun Zhu,Carmen Argmann,Robert M. O'Doherty,David G. Peters,Donald K. Scott
Molecular Metabolism.2017;6(4)327
[DOI]
17Dietary supplementation of vitamin D prevents the development of western diet-induced metabolic, hepatic and cardiovascular abnormalities in rats
Giovanna Mazzone,Carmine Morisco,Vincenzo Lembo,Giuseppe D’Argenio,Maria D’Armiento,Antonella Rossi,Carmine Giudice,Bruno Trimarco,Nicola Caporaso,Filomena Morisco
United European Gastroenterology Journal.2018;6(7)1056
[DOI]
18Model-based cost-effectiveness analysis of atorvastatin drugs for prevention of cardiovascular diseases in Iran
Alireza Jabbari,Abdosaleh Jafari,Marziye Hadian,Mohammad Ghasemi
International Journal of Preventive Medicine.2020;11(1)57
[DOI]
19An Observational Study of Reduction in Glycemic Parameters and Liver Stiffness by Saroglitazar 4 mg in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
Asis Mitra
Cureus.2020;11(1)57
[DOI]
20Metabolic clinic for individuals with HIV/AIDS: a commitment and vision to the future of HIV services
Mohamed H. Ahmed,Clare Woodward,Dushyant Mital
Cardiovascular Endocrinology.2017;6(3)109
[DOI]
21Non-alcoholic fatty liver disease. Role of primary care physicians
Juan Caballeria,Llorenç Caballeria
Medicina Clínica (English Edition).2015;145(3)112
[DOI]
22Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
Heidi Storgaard,Lise L. Gluud,Cathy Bennett,Magnus F. Grøndahl,Mikkel B. Christensen,Filip K. Knop,Tina Vilsbøll,Noel Christopher Barengo
PLOS ONE.2016;11(11)e0166125
[DOI]
23Establishment of a Risk Prediction Model for Non-alcoholic Fatty Liver Disease in Type 2 Diabetes
Yali Zhang,Rong Shi,Liang Yu,Liping Ji,Min Li,Fan Hu
Diabetes Therapy.2020;11(9)2057
[DOI]
24Polyphenol-Rich Fraction of Ecklonia cava Improves Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice
Eun-Young Park,Hojung Choi,Ji-Young Yoon,In-Young Lee,Youngwan Seo,Hong-Seop Moon,Jong-Hee Hwang,Hee-Sook Jun
Marine Drugs.2015;13(11)6866
[DOI]
Feedback
Subscribe


Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal